Clinical Trials Directory

Trials / Completed

CompletedNCT05488899

Ultra Low Iodine Loaded Spectral CT Angiography (CTA)

Ultra Low Iodine Loaded Spectral CT Angiography (CTA) of the Aorta and Lower Limb: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
216 (actual)
Sponsor
University Hospital, Akershus · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objectives of this study are: Evaluation of ultra-low iodine load CTA protocols of the aorta and lower extremities. To investigate whether dual-layer in combination with with virtual monoenergetic imaging (VMI) allows for reduction of contrast medium (CM) in CTA of the aorta and lower limbs i with sustained objective and subjective image quality parameters.

Detailed description

CT angiography (CTA) of the aorta and the lower limb is one of the most important tools for diagnostic, evaluation of the severity of the peripheral arterial disease, decision making, treatment planning and follow-up; but usually requires the use of iodine contrast medium. Due to the high prevalence of renal impairment (eGFR \< 90 ml/min/1.73m) in the elderly hospitalized population (more than 90% among inpatients aged over 60 years) contrast-medium-induced nephropathy is a major concern in this population. The recently introduced spectral CT technique utilizes x-rays covering a spectrum of energy-levels as opposed to conventional CT in which x-rays are set to one specific energy level. This technology offers many possibilities, such as "boosting" the x-ray contrast effect of iodine. This improves the vascular enhancement of the contrast medium using low-energy, virtual monoenergetic imaging (VNI). The objectives of this study are: Evaluation of ultra-low iodine load CTA protocols of the aorta and lower extremities. To investigate whether dual-layer in combination with with virtual monoenergetic imaging (VMI) allows for reduction of contrast medium (CM) in CTA of the aorta and lower limbs i with sustained objective and subjective image quality parameters.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHalf iodine Spectral CTPatients receive half dosage of iodine contrast agent, and Spectral CT acquisition with Virtual Monoenergetic Images at 40 and 50 keV.
DIAGNOSTIC_TESTStandard iodine conventional CTPatients receive standard dosage of iodine contrast agent, and conventional 120 kv Polychromatic CT acquisition.

Timeline

Start date
2019-01-28
Primary completion
2020-10-16
Completion
2020-10-16
First posted
2022-08-05
Last updated
2022-08-05

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT05488899. Inclusion in this directory is not an endorsement.